Ryuhei Sano
Setagaya, 1568502, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 14 publications
Effects of salt supplementation in uninephrectomized KK-Ay mice: Examining the potential of a diabetic kidney disease model.
Journal: The Journal of toxicological sciences
Published: November 01, 2023
High-cholesterol diet in combination with hydroxypropyl-beta-cyclodextrin induces NASH-like disorders in the liver of rats.
Journal: Physiological research
Published: July 14, 2023
Establishment of a new nonalcoholic steatohepatitis model; Ovariectomy exacerbates nonalcoholic steatohepatitis-like pathology in diabetic rats.
Journal: Journal of pharmacological and toxicological methods
Published: February 22, 2022
Immune disorders and sex differences in spontaneously diabetic Torii rats, type 2 diabetic model.
Journal: Physiological research
Published: January 19, 2022
Correction to: A trans fatty acid substitute enhanced development of liver proliferative lesions induced in mice by feeding a cholinedeficient, methionine-lowered, L-amino acid-defined, high-fat diet.
Journal: Lipids in health and disease
Published: January 08, 2022
Nonobese mice with nonalcoholic steatohepatitis fed on a choline-deficient, l-amino acid-defined, high-fat diet exhibit alterations in signaling pathways.
Journal: FEBS open bio
Published: March 17, 2021
Glomerular hyperfiltration with hyperglycemia in the spontaneously diabetic Torii (SDT) fatty rat, an obese type 2 diabetic model.
Journal: Physiological research
Published: January 17, 2021
A trans fatty acid substitute enhanced development of liver proliferative lesions induced in mice by feeding a choline-deficient, methionine-lowered, L-amino acid-defined, high-fat diet.
Journal: Lipids in health and disease
Published: September 11, 2020
Sodium-glucose cotransporters: Functional properties and pharmaceutical potential.
Journal: Journal of diabetes investigation
Published: January 03, 2020
A Novel TNF-α Converting Enzyme (TACE) Selective Inhibitor JTP-96193 Prevents Insulin Resistance in KK-Ay Type 2 Diabetic Mice and Diabetic Peripheral Neuropathy in Type 1 Diabetic Mice.
Journal: Biological & pharmaceutical bulletin
Published: November 06, 2019
Discovery of potent liver-selective stearoyl-CoA desaturase-1 (SCD1) inhibitors, thiazole-4-acetic acid derivatives, for the treatment of diabetes, hepatic steatosis, and obesity.
Journal: European journal of medicinal chemistry
Published: June 18, 2018
JTP-103237, a monoacylglycerol acyltransferase inhibitor, prevents fatty liver and suppresses both triglyceride synthesis and de novo lipogenesis.
Journal: Journal of pharmacological sciences
Published: April 09, 2015
Last Updated: 09/26/2026